ANVS

Conviction 23HealthcareScan · Mon, Aug 10, 2026

ANVS$1.87-0.53%

ResistanceSupportVol 14Insider buy

Vol MA14 620.08K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Annovis Bio, Inc.PHARMACEUTICAL PREPARATIONSwww.annovisbio.com ↗

Price1.87

Change-0.53%

Gap+0.00%

Rel volume1.44×

Avg volume641.13K

Avg $ vol1.13M

SMA 201.76

SMA 501.80

SMA 2002.50

Price vs 50+3.76%

Price vs 200-25.21%

MA stackmixed

50/200 cross—

Supertrenddown · 1.95

RSI (14)56

MACD hist0.02

MACD crossbull · 6d

Stoch %K / %D75 / 75

ADX (14)14

+DI / −DI24 / 16

RSI divergence—

MACD divergence—

ATR %+5.74%

ADR %5.38%

52w high5.10

52w low1.59

From 52w high-63.33%

Above 52w low+17.61%

New 52w highNo

SqueezeFired

Bollinger width16.01%

%B0.88

Donchian pos75.12%

Donchian high1.98

Donchian low1.55

AVWAP (52w high)2.37

vs AVWAP high-20.99%

AVWAP (52w low)1.90

vs AVWAP low-1.61%

OBV trendFlat

Chaikin MF (20)-0.07

Today vs 20d1.44×

Avg vol (14d)620.08K

Avg vol (20d)641.13K

Avg $ vol (20d)1.13M

Market cap64.79M

RS 3m (vs SPY)-22.51%

RS 6m (vs SPY)-37.06%

RS line new highNo

Trend template1/8

Technical rank34.3

1 week+8.72%

1 month+0.54%

3 months-17.98%

6 months-24.90%

1 year-28.08%

YTD-48.77%

P/E-2.25

P/B20.73

P/S—

P/FCF—

EPS-1.40

Div yield—

ROE-923.02%

ROA-177.63%

Debt/Eq—

Current0.61

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-17.34%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value50.57M

Revenue0

Net income-17.61M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out34.65M

Employees7

ListedWed, Jan 29, 2020

Free float22.24M

Float %83.9%

Short interest5.45M

Days to cover5.0d

Short volume62.2%

Squeeze score86 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction23 / 100

Pattern quality—

Tech rank34.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.07

Support1.60

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANVS

All disclosures →

No recent disclosed trades by Congress in ANVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANVS · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Hoffman Michael B Director · Common Stock · 2026-05-20	Buy	54.93K	$104K	2026-05-20	2026-05-21
Hoffman Michael B Director · Common Stock · 2026-05-20	Buy	2.56K	$4K	2026-05-20	2026-05-21
Hoffman Michael B Director · Common Stock · 2026-05-20	Other	—	—	2026-05-20	2026-05-21
Hoffman Michael B Director · Common Stock · 2026-05-20	Buy	18.85K	$34K	2026-05-20	2026-05-21

SEC filings

EDGAR filings in ANVS · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.